The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Segerfalk Symposium 2025

Advances in Alzheimer’s Disease Research: From Experimental Models to Translational and Clinical Research

Venue: BMC D – Belfragesalen
Date: Tuesday, May 13th, 2025

Registration Link

Program


8:30 - 8:40
Welcome

Morning Theme: Disease Mechanisms of Alzheimer’s Disease - From Experimental to Translational Neuroscience

8:40 - 9:25
Lessons from Cell Models on the Role of Lipid Metabolism and APOE in AD Disease Mechanisms
Rik van der Kant, VU Amsterdam, the Netherlands

9:25 - 10:10
Multimodal Neuroimaging to Advance Our Understanding of Preclinical Alzheimer’s Disease
Sylvia Villeneuve, McGill University, Canada

10:10 - 10:25
Coffee Break

10:25 - 10:55
Tau PET in Alzheimer’s Disease
Rik Ossenkoppele, Lund University, Sweden, and Amsterdam UMC, the Netherlands

10:55 - 11:25
PET Studies in Non-AD Dementias
Maura Malpetti, University of Cambridge, UK

11:25 - 11:55
Integrating Molecular Imaging and Genomics for Alzheimer’s Disease
Andre Altmann, University College London, UK

11:55 - 12:25
Bridging Advanced Computational Developments and Multi-Omics for Studies of Alzheimer’s Disease
Jacob Vogel, Lund University, Sweden

12:25 - 13:15
Lunch Break

Afternoon Theme: Towards a New Clinical Practice for Alzheimer’s Disease

13:15 - 14:00
The Future Role of Neuroimaging in Alzheimer’s Disease
Gaël Chetelat, Normandy University, France

14:00 - 14:30
Clinical Relevance of Tau PET Patterns
Rosaleena Mohanty, Karolinska Institute, Sweden

14:30 - 14:45
Coffee Break

14:45 - 15:15
Plasma Biomarkers vs Molecular Imaging in Clinical Practice
Niklas Mattsson-Carlgren, Lund University, Sweden

15:15 - 16:00
Datablitz Talks (10 min each with 5 min Q&A)

  1. Time-Dependent Impact of Apolipoprotein E4 on Endolysosomal Function in Primary Neurons
    Emma Nyberg, Lund University, Sweden
  2. Lower Antemortem Tau PET Retention in Males and Older Individuals is Explained by Lower Postmortem Tau Tangle Density
    Emma Coomans, Amsterdam UMC, the Netherlands
  3. Plasma Biomarkers in a New Alzheimer’s Disease Era
    Gemma Salvado, Lund University, Sweden, and Barcelona Beta, Spain

16:00 - 17:00
Drinks and Refreshments
 

Organisers: Niklas Mattsson-Carlgren & Rik‬‭ Ossenkoppele‬‬‬‬‬‬‬‬‬

This event is sponsored by The Thorsten and Elsa Segerfalk Foundation & MultiPark

Brain